ASCO and ONS launch collaboration to advance engagement in CancerLinQ

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

CancerLinQ LLC, a wholly-owned nonprofit subsidiary of the American Society of Clinical Oncology, and the Oncology Nursing Society announced the formation of the CancerLinQ Ambassadors Program.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login